The administration of leuprorelin acetate after radical #prostatectomy does not provide survival benefits in patients with nonmetastatic, high-risk #prostatecancer who have undetectable prostate-specific antigen levels. Reported in @eururoloncol.bsky.social.
https://bit.ly/4sHEEJw
#pcsm